The pandemic had a huge impact on where and how people seek out medical information and advice, with a large percentage of people becoming far less likely to follow a more traditional route
The information age has produced a generation of young people concerned about their health, but distrustful of big brands – and that includes the pharmaceutical industry.
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
